Drug Shortage Report for TARO-DEFERASIROX
| Report ID | 57516 |
| Drug Identification Number | 02463520 |
| Brand name | TARO-DEFERASIROX |
| Common or Proper name | TARO DEFERASIROX |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEFERASIROX |
| Strength(s) | 125MG |
| Dosage form(s) | TABLET FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 30's |
| ATC code | V03AC |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-08-02 |
| Estimated end date | 2018-11-09 |
| Actual end date | 2018-10-26 |
| Shortage status | Resolved |
| Updated date | 2019-02-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2019-02-04 | French | Compare |
| v9 | 2019-02-04 | English | Compare |
| v8 | 2018-10-30 | French | Compare |
| v7 | 2018-10-30 | English | Compare |
| v6 | 2018-10-16 | French | Compare |
| v5 | 2018-10-16 | English | Compare |
| v4 | 2018-09-07 | French | Compare |
| v3 | 2018-09-07 | English | Compare |
| v2 | 2018-08-03 | French | Compare |
| v1 | 2018-08-03 | English | Compare |
Showing 1 to 10 of 10